Ticker LaunchReverse merger · Completed · AADI
Aadi Bioscience, Inc.
Reverse merger with Aerpio Pharmaceuticals, Inc.
Aadi Bioscience, Inc. merged into Aerpio Pharmaceuticals, Inc., a Nasdaq-listed biopharmaceutical company, in a reverse merger that takes the private company public. The deal was announced on May 17, 2021 and closed on Aug 26, 2021. The combined company trades as Aadi Bioscience, Inc. (AADI) on Nasdaq.
Aadi Bioscience, Inc. is a biopharmaceutical company advancing late-stage therapies for genetically-defined cancers with mTOR pathway gene alterations, led by FYARRO (sirolimus albumin-bound nanoparticles).
- Status
- Completed
- Private company
- Aadi Bioscience, Inc.
- Public company
- Aerpio Pharmaceuticals, Inc.
- Public company business before
- Nasdaq-listed biopharmaceutical company
- Announced
- May 17, 2021
- Closed
- Aug 26, 2021
- Combined company
- Aadi Bioscience, Inc. (AADI)
- Exchange
- Nasdaq
- Sector
- Biotech & pharma
More on this deal for subscribers
- Ownership split between private and public holders
- Concurrent financing and investors
- Contingent value rights (CVR)
- Reverse stock split
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Closing 8-K Aug 27, 2021
- Closing press release / exhibit
- Announcement 8-K May 17, 2021
- Announcement press release
- All filings on EDGAR CIK 1422142
Other completed reverse mergers
- Allied Integral United, Inc. (AIU)into Superconductor Technologies Inc. · Sep 9, 2021
- Mace Corporationinto Peregrine Industries, Inc. · Sep 3, 2021
- CNP Operating, LLCinto CFN Enterprises Inc. · Aug 25, 2021
- Stemtech Corporationinto Globe Net Wireless Corp. · Aug 19, 2021
- Tingo Mobile PLCinto IWEB, Inc. · Aug 15, 2021
- HyEdge, Inc.into FICAAR, Inc. · Aug 11, 2021